Multiomics Market Size, Trends and Insights By Type (Single-cell Multiomics, Bulk Multiomics), By Platform (Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms), By Application (Cell Biology, Oncology, Neurology, Immunology), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
The global multiomics market was valued at USD 2.7 Bn in 2024 and is projected to reach USD 7.6 Bn by 2033, growing at a CAGR of 15.2%. Europe is the largest regional market and Asia-Pacific is growing fastest.
Global Multiomics Market was valued at USD 2.7 Billion in 2024 and is expected to reach USD 7.6 Billion by 2033, at a CAGR of 15.2% during the forecast period 2024 - 2033.
Multiomics is the study of biological systems using various omics technologies such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics, among others. Each omic field focuses on a unique element of biological molecules.
Multiomics Market Growth Factors
High demand in pharmaceuticals
The strong demand for multiomic solutions in pharmaceuticals is driving significant growth in the multiomic market. Multiomics is the complete analysis of several omics data sets, including genomes, transcriptomics, proteomics, metabolomics, and epigenomics, to gain a holistic knowledge of biological systems.
In the pharmaceutical sector, this method provides unrivalled insights into illness processes, treatment reactions, and patient variation. Integrating data from numerous omics levels allows researchers to unravel intricate molecular relationships, identify biomarkers for illness diagnosis and prognosis, and discover novel therapeutic targets.
The increased frequency of complicated diseases such as cancer, cardiovascular ailments, and neurological conditions, where standard single-omics approaches may not provide significant insights, is driving demand for multiomic solutions even more.
Furthermore, advances in high-throughput omics technologies, data analytics, and computational modelling are improving the feasibility and scalability of multiomic investigations, which is driving the growth of the multiomic market in the pharmaceutical industry.
Growing adoption in crop breeding
The growing use of multiomics approaches in crop breeding is profoundly transforming agricultural innovation and production. Researchers get a complete understanding of plant life at the molecular level by combining multiple omics disciplines such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics.
This comprehensive method allows for an exact definition of plant features, identification of key genes responsible for desirable traits, and deciphering complex regulatory networks that govern crop development, stress responses, and yield potential.
Furthermore, multiomics techniques speed the breeding process by allowing for high-throughput screening of genetic variants and phenotype-genotype correlations, reducing the time required to generate new cultivars.
The use of multiomics in crop breeding not only speeds up the production of resilient and high-yielding crops, but also addresses global issues including food security, climate change, and sustainable agriculture.
As a result, the increasing adoption of multiomics techniques in crop breeding is propelling the multiomics market forward, as stakeholders across the agricultural sector recognize its potential to revolutionize the enhancement of crops and meet the growing demand for nutritious and sustainable food production.
Multiomics Market: Restraints
High setup cost
High startup expenses associated with multiomics research can severely impede market expansion. Multiomics, which combines several omics technologies including genomes, transcriptomics, proteomics, metabolomics, and epigenomics, provides a holistic understanding of biological systems.
However, the deployment of multiomics techniques necessitates a significant investment in advanced equipment, specialized software, and highly trained individuals. Furthermore, the intricacy of integrating data from different omics layers necessitates strong computational infrastructure and knowledge, which raises the financial burden.
As a result, many researchers may lack the means to create and maintain multiomics facilities, limiting access to advanced techniques and hampering wider adoption and innovation in the area.
Solving these cost barriers through collaborative efforts, innovations in technology that reduce expenses, and funding initiatives could lead to increased participation and advancement in multiomics research, ultimately driving its wider use and impact in understanding complex biological systems.
Multiomics Market: Opportunities
Demand for personalized medicines
The growing demand for personalized treatments is a major factor driving the multiomics market forward. Personalized medicine seeks to match medical treatments to individual factors such as genetic makeup, lifestyle, and environment to increase efficacy while minimizing side effects.
Multiomics is an interdisciplinary technique that integrates data from numerous omics disciplines, including genomes, transcriptomics, proteomics, metabolomics, and epigenomics, to provide full insights into an individual's biological profile.
Using multiomics technologies, healthcare practitioners can acquire a more individualized understanding of the complex biological mechanisms driving diseases and therapeutic responses. This permits the discovery of biomarkers for disease diagnosis, prognosis, and treatment selection, resulting in more precise and successful therapeutic interventions.
Moreover, the introduction of high-throughput sequencing and sophisticated analytical techniques has dramatically lowered the cost and time necessary for multiomics analysis, making it more practical for everyday clinical applications.
As an outcome, the incorporation of multiomics techniques into healthcare practices is becoming more common, fuelling the growth of the multiomics market as it plays a critical part in customized medicine.
Multiomics Market: Segmentation Analysis
The global Multiomics market is segmented by type, platform, application, and region. Based on type, the market is classified into single-cell multi-omics and bulk multi-omics. Bulk Multi-Omics dominated the market in 2023 with a market share of 60.3% and is expected to keep its dominance during the forecast period 2024-2033.
Bulk multi-omics, which integrates several omics datasets (e.g., genomes, transcriptomics, proteomics, metabolomics, and epigenomics) at scale, is transforming biomedical research and personalized treatment.
Bulk multi-omics provides a holistic picture of biological systems, allowing researchers to identify intricate relationships and patterns at several molecular levels, leading to greater insights into disease causes, treatment responses, and biomarker development.
The rise of bulk multi-omics applications, fuelled by advances in high-throughput sequencing, mass spectrometry, and bioinformatics tools, is propelling the multiomics market forward.
As scientists increasingly recognize the value of multi-omics approaches in addressing complex biological questions, demand for bulk multi-omics solutions is expected to drive market growth, with implications ranging from basic research to medical diagnostics and precision medicine initiatives.
Based on platform, the market is classified into genomics, transcriptomics, proteomics, metabolomics and integrated omics platforms. Genomics dominated the market in 2023 with a market share of 30.5% and is expected to keep its dominance during the forecast period 2024-2033.
Genomics, the study of an organism's entire DNA sequence, is critical to driving the multiomics business, which combines data from several omics domains such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics.
Genomics generates foundational data by sequencing an organism's genome, exposing its genetic blueprint and variations. By merging genomic data with other omics information, researchers get a comprehensive understanding of biological systems, disease processes, and tailored medicine.
For example, integrating genomics and transcriptomics allows for the investigation of transcription patterns, whereas combining genomics and proteomics allows for the identification of proteins encoded by genes. These multiomics approaches enable a better understanding of complex biological processes, which speeds up drug discovery, biomarker identification, and precision medicine initiatives.
Based on application, the market is classified into oncology, cell biology, neurology, immunology and others. Oncology dominated the market in 2023 with a market share of 34.5% and is expected to keep its dominance during the forecast period 2024-2033.
Oncology is moving the multiomics market ahead due to the requirement for comprehensive, individualized cancer treatments. Multiomics, which combines data from several "-omics" disciplines like genomes, transcriptomics, proteomics, and metabolomics, provides a comprehensive perspective of cancer biology, allowing for a better understanding of the illness and its processes.
Combining genomic, transcriptomic, and proteomic data allows clinicians to find complicated molecular pathways driving cancer growth, resistance mechanisms, and possible treatment targets. This multiomic approach not only improves the knowledge of cancer biology but also allows for the discovery and development of new therapies and precision medicine tactics, ultimately improving patient outcomes and changing cancer care.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 2.7 Billion |
| Projected Market Size in 2033 | USD 7.6 Billion |
| Market Size in 2023 | USD 2.3 Billion |
| CAGR Growth Rate | 15.2% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Type, Platform, Application and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Multiomics Market: Regional Analysis
By region, Multiomics market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. North America dominated the global Multiomics market in 2023 with a market share of 39.1% and is expected to keep its dominance during the forecast period 2024-2033.
North America dominates the multiomics industry due to a combination of strong research infrastructure, technological developments, and significant expenditure in healthcare. The region has a large network of premier academic institutions, research centres, and pharmaceutical businesses, which promotes innovation and collaboration in multiomics research.
Furthermore, North America's emphasis on precision medicine and individualized healthcare has accelerated the use of multiomics techniques, which allow for complete investigation of biological systems at numerous molecular levels.
The United States, in particular, stands out as a major contributor to the growth of the multiomics market, because of its strong biotechnology sector and a favourable regulatory environment that encourages the development and commercialization of multiomics technologies and services.
Moreover, the region's high healthcare spending and growing emphasis on genetic medicine increase demand for multiomics solutions that provide insights into disease causes, biomarker development, and therapeutic targeting.
Overall, North America's leadership in multiomics research and commitment to improving healthcare through molecular analysis position it as a key driver of the global multiomics market.
Source: Custom Market Insights analysis.
To learn more about this report - request a sample report PDF
Multiomics Market Recent Developments
List of the prominent players in the Multiomics Market:
These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.
The Multiomics Market is segmented as follows:
Regional Coverage:
North America
Europe
Asia Pacific
The Middle East & Africa
Latin America
Updated: January 2026 · Formats: PDF, Excel, PPT
The major driver for the Multiomics market is high demand in pharmaceuticals and growing adoption in crop breeding.
The "Cell Biology" had the largest share in the global market for Multiomics.
The "Single-cell Multiomics" category dominated the market in 2023.
The key players in the market are Thermo Fisher Scientific Inc., Illumina Inc., Agilent Technologies Inc., Qiagen N.V., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Waters Corporation, Danaher Corporation, Roche Holding AG, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Eurofins Scientific, BGI Group, GenScript Biotech Corporation, NanoString Technologies Inc., Takara Bio Inc., GE Healthcare, Beckman Coulter Inc. , 10x Genomics Inc., Others.
"North America" had the largest share in the Multiomics Market.
The global market is projected to grow at a CAGR of 15.2% during the forecast period, 2024-2033.
The Multiomics Market size was valued at USD 2.7 Billion in 2024.
Author · Sr. Research Analyst
Ayush Kadam is a Senior Market Research Analyst at Custom Market Insights, with over seven years of experience in syndicated and custom market research. He specializes in market sizing, competitive intelligence, industry trends, forecasting, and strategic insights, helping clients turn complex data into actionable business decisions.
Buy individual chapters for $490 each: 8 chapters available, from Executive Summary to Company Profiles.
Get the full report structure, sample pages and data tables in the free sample.
Download free sampleGet the full report structure, sample pages and data tables in the free sample.
Download free sampleGet the full report structure, sample pages and data tables in the free sample.
Download free sample